• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

Part­ner­ing with Am­gen vet Sean Harp­er, vet­er­an VC Beth Sei­den­berg un­veils a $320M fund and a unique fo­cus on…wait ...

7 years ago
People
Financing

Once a block­buster-to-be, Te­va fi­nal­ly sounds taps for its PhI­II los­er laquin­i­mod

7 years ago
R&D
Pharma

David Schenkein is pass­ing the reins at Agios to Jack­ie Fouse af­ter a star-mak­ing 10-year run

7 years ago
People

Brain­storm re­cruits No­var­tis vet Araya as chief com­mer­cial of­fi­cer; Roche out-li­cens­es IPF drug to Shang­hai's Ark

7 years ago
News Briefing

Sanofi reaps first fruit of Abl­ynx buy­out with a Eu­ro­pean OK for its lead rare dis­ease drug

7 years ago
Pharma

An­oth­er Shkre­li-like drug price con­tro­ver­sy? Lea­di­ant finds it­self in the spot­light af­ter 500-fold price hike — FT

7 years ago
Pharma

New re­port re-ig­nites fresh buzz that Bay­er is prep­ping an R&D over­haul and job cuts

7 years ago
R&D

Strug­gling MannKind sees shares rock­et up on $105M-plus al­liance with Unit­ed on in­haled tre­pros­tinil

7 years ago
Pharma

The high-roller club in bio­phar­ma: Who’s pay­ing top-dol­lar for up­fronts? And who are the busiest play­ers at the ...

7 years ago
R&D
Pharma

Ox­ford spin­out Evox grabs a $45M bankroll to ad­vance to the clin­ic with new ex­o­some tech

7 years ago
Financing

Il­lus­tri­ous Cam­bridge sci­en­tists join forces with $129M fund to bet on long plays in biotech

7 years ago
Financing

Glax­o­SmithK­line sci­en­tist cops a guilty plea in scheme to sell the phar­ma gi­ant's drug re­search in Chi­na

7 years ago
China

Ed­i­tas CMO to ex­it as CRISPR tech gears up; Roche di­ag­nos­tics di­vi­sion CEO Roland Diggel­mann is out

7 years ago
Peer Review

Chi­na reg­u­la­tors launch a re­view for BeiGene’s PD-1; PureTech co-founder hops to Long­wood Fund

7 years ago
News Briefing

Once charged with speed­ing up Eli Lil­ly’s slow-mo R&D group, Anne White is hand­ed the reins at Lil­ly On­col­o­gy

7 years ago
People

Com­ing to Amer­i­ca: Re­han Ver­jee jumps up to top US health­care post for Mer­ck KGaA in high-lev­el re­vamp

7 years ago
People

Look­ing to re­tain its run­ner-up po­si­tion in HIV, Mer­ck scores two new ap­provals for HIV ther­a­pies

7 years ago
Pharma

Qim­ing, Hill­house bet on Ja­co­bio's nascent pipeline of first-in-class drug hope­fuls in $55M round

7 years ago
Financing
China

In lat­est set­back, As­traZeneca’s high hopes for its lu­pus drug an­i­frol­um­ab crushed by a PhI­II fail­ure

7 years ago
R&D

Al­lied with Genen­tech and Pfiz­er on dis­cov­ery deals, pro­tein degra­da­tion crew at Arv­inas looks for $100M IPO ahead of ...

7 years ago
Financing

As R&D set­backs mul­ti­ply, a pi­o­neer­ing CRISPR/Cas9 pro­gram for Duchenne MD con­tin­ues to im­press in new dog study

7 years ago
Discovery

Al­ny­lam makes RNAi his­to­ry again as patisir­an gets ap­proved in Eu­rope; Ver­tex buys in­to UK-based ma­chine learn­ing ...

7 years ago
News Briefing

Bay­er gets green light to sell long-act­ing he­mo­phil­ia A ther­a­py as Roche mus­cles in with Hem­li­bra

7 years ago
Pharma

Pfiz­er ax­es a key Duchenne MD pro­gram af­ter PhII flop, rais­ing new doubts for a drug cat­e­go­ry that at­tract­ed Roche ...

7 years ago
R&D
First page Previous page 999100010011002100310041005 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.